Harbinger Health Appoints May Orfali, M.D. as Chief Medical Officer
Dr. Orfali brings over 25 years of experience across biopharma clinical development and medical practiceAppointment comes at period of rapid growt...
Stay updated with breaking news from Bioasis Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr. Orfali brings over 25 years of experience across biopharma clinical development and medical practiceAppointment comes at period of rapid growt...
Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) was the recipient of a large decline in short interest during the month of April. As of April 30th, there was short interest totalling 17,200 shares, a decline of 13.1% from the April 15th total of 19,800 shares. Based on an average daily volume of 8,500 shares, the […]
Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) saw a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 19,800 shares, an increase of 18.6% from the March 31st total of 16,700 shares. Based on an average daily trading volume, of 3,000 shares, the days-to-cover ratio […]
28 April 2023 Biodexa Pharmaceuticals PLC Preliminary Results for the Year Ended 31 December 2022 Biodexa Pharmaceuticals PLC ,... | April 28, 2023
Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) was the recipient of a significant decline in short interest during the month of March. As of March 31st, there was short interest totalling 16,700 shares, a decline of 42.0% from the March 15th total of 28,800 shares. Based on an average daily volume of 9,400 shares, the […]